AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 269: H46-H52, 1995;
0363-6135/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shih, C. D.
Right arrow Articles by Chan, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shih, C. D.
Right arrow Articles by Chan, J. Y.

AJP - Heart and Circulatory Physiology, Vol 269, Issue 1 46-H52, Copyright © 1995 by American Physiological Society


ARTICLES

Participation of hypothalamic paraventricular nucleus in locus ceruleus-induced baroreflex suppression in rats

C. D. Shih, S. H. Chan and J. Y. Chan
Institute of Physiology, National Yang-Ming University, Taipei, Taiwan, Republic of China.

We evaluated the potential role of the paraventricular nucleus (PVN) of the hypothalamus in the suppression of baroreceptor reflex (BRR) response by locus ceruleus (LC), using adult male Sprague-Dawley rats anesthetized with pentobarbital sodium. Electrical stimulation of histologically verified sites in the LC elicited significant reduction in the BRR response. This suppressive effect of LC on BRR response was appreciably antagonized by bilateral electrolytic lesions of the PVN and reversibly blocked by bilateral microinjection of 2% lidocaine into similar hypothalamic loci. Local administration of the alpha 1-adrenoceptor antagonist, prazosin (50 pmol), or an antiserum directed against neuropeptide Y (NPY) (1:20) into the bilateral PVN also significantly attenuated the suppression elicited by LC on BRR response. In contrast, treatments with the alpha 2-adrenoceptor blocker, yohimbine (50 pmol), heat-inactivated NPY antiserum (1:20), artificial cerebrospinal fluid, or normal rabbit serum (1:20) produced no discernible effect. These results suggest that the PVN may constitute part of the efferent pathways through which LC elicits its inhibition on the BRR response. Furthermore, LC may activate this pathway via alpha 1-adrenoceptors and NPY receptors in the PVN.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. B. Evans, C. W. Wilkinson, P. Gronbeck, J. L. Bennett, A. Zavosh, G. J. Taborsky Jr, and D. P. Figlewicz
Inactivation of the DMH selectively inhibits the ACTH and corticosterone responses to hypoglycemia
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R123 - R128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K.-R. Hwang, S. H. H. Chan, and J. Y. H. Chan
Noradrenergic neurotransmission at PVN in locus ceruleus-induced baroreflex suppression in rats
Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1284 - H1292.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online